Co-Authors
This is a "connection" page, showing publications co-authored by Shinyu Izumi and Masaki Okamoto.
Connection Strength
0.119
-
Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure. Infect Dis Ther. 2021 Dec; 10(4):2353-2369.
Score: 0.060
-
Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study. Sci Rep. 2021 05 21; 11(1):10727.
Score: 0.059